These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2084460)

  • 1. Rapid improvement in the chemical pathology of congenital erythropoietic porphyria with treatment with superactivated charcoal.
    Tishler PV; Winston SH
    Methods Find Exp Clin Pharmacol; 1990 Nov; 12(9):645-8. PubMed ID: 2084460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porphyrins in urine, plasma, erythrocytes, bile and faeces in a case of congenital erythropoietic porphyria (Gunther's disease) treated with blood transfusion and iron chelation: lack of benefit from oral charcoal.
    Gorchein A; Guo R; Lim CK; Raimundo A; Pullon HW; Bellingham AJ
    Biomed Chromatogr; 1998; 12(6):350-6. PubMed ID: 9861496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sorbent therapy of the porphyrias. IV. Adsorption of porphyrins by sorbents in vitro.
    Tishler PV; Winston SH
    Methods Find Exp Clin Pharmacol; 1985 Sep; 7(9):485-91. PubMed ID: 4079600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of oral activated charcoal on the course of congenital erythropoietic porphyria.
    Hift RJ; Meissner PN; Kirsch RE
    Br J Dermatol; 1993 Jul; 129(1):14-7. PubMed ID: 8369205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic efficacy of oral charcoal in congenital erythropoietic porphyria.
    Pimstone NR; Gandhi SN; Mukerji SK
    N Engl J Med; 1987 Feb; 316(7):390-3. PubMed ID: 3100953
    [No Abstract]   [Full Text] [Related]  

  • 6. A plasma porphyrin fluorescence marker for variegate porphyria.
    Poh-Fitzpatrick MB
    Arch Dermatol; 1980 May; 116(5):543-7. PubMed ID: 7377785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of serum and urinary porphyrin levels in porphyria cutanea tarda.
    Kalb RE; Grossman ME; Poh-Fitzpatrick MB
    Arch Dermatol; 1985 Oct; 121(10):1289-91. PubMed ID: 4037823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral charcoal therapy of congenital erythropoietic porphyria.
    Tishler PV
    Hepatology; 1988; 8(1):183-4. PubMed ID: 3338705
    [No Abstract]   [Full Text] [Related]  

  • 9. Biochemical diagnosis and monitoring therapeutic modulation of disease activity in an unusual case of congenital erythropoietic porphyria.
    Mukerji SK; Pimstone NR; Gandhi SN; Tan KT
    Clin Chem; 1985 Dec; 31(12):1946-51. PubMed ID: 4064282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Porphyrin distribution and porphyrin excretion in human congenital erythropoietic porphyria.
    Eriksen L; Eriksen N
    Scand J Clin Lab Invest; 1974 Jun; 33(4):323-32. PubMed ID: 4853698
    [No Abstract]   [Full Text] [Related]  

  • 11. Follow-up studies of porphyrin excretion in porphyria cutanea tarda treated with p-aminobenzoic acid.
    de Salamanca RE; Peña ML; Olmos A; Molina C; Ladero JM
    Ann Clin Res; 1980 Dec; 12(6):279-81. PubMed ID: 6972189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sorbent therapy of the porphyrias. V. Adsorption of the porphyrin precursors delta-aminolevulinic acid and porphobilinogen by sorbents in vitro.
    Winston SH; Tishler PV
    Methods Find Exp Clin Pharmacol; 1986 Apr; 8(4):233-7. PubMed ID: 3724299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repression by hematin of porphyrin biosynthesis in erythrocyte precursors in congenital erythropoietic porphyria.
    Watson CJ; Bossenmaier I; Cardinal R; Petryka ZJ
    Proc Natl Acad Sci U S A; 1974 Feb; 71(2):278-82. PubMed ID: 4521800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porphyria variegata: failure of chloroquin treatment.
    Cramers M; Jepsen LV
    Acta Derm Venereol; 1980; 60(1):89-91. PubMed ID: 6153849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Carbolen in the treatment of late porphyria of the skin].
    Pankov BS
    Vestn Dermatol Venerol; 1967 Apr; 41(4):67-70. PubMed ID: 5611845
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of porphyria cutanea tarda with intermittent chloroquine].
    Raff M; Formanek I
    Hautarzt; 1980 Aug; 31(8):437-40. PubMed ID: 7451150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation and clinical application of the Enterotest for the determination of human biliary porphyrin composition.
    Beukeveld GJ; Bijleveld CM; Kuipers F; Kreeftenberg HG; Huizenga JR; te Velde K; Wolthers BG
    Eur J Clin Chem Clin Biochem; 1995 Jul; 33(7):453-62. PubMed ID: 7548456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of oral activated charcoal in variegate porphyria results in a paradoxical clinical and biochemical deterioration.
    Hift RJ; Todd G; Meissner PN; Kirsch RE
    Br J Dermatol; 2003 Dec; 149(6):1266-9. PubMed ID: 14674906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital erythropoietic porphyria. A case report with discussion of different porphyrin excretion patterns.
    Dahle JS; Eriksen L; Romslo I; Thune P
    Photodermatol; 1984 Aug; 1(4):187-90. PubMed ID: 6531292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The first Swedish case of congenital erythropoietic porphyria, with a revised view of the porphyrin excretion pattern in this disease.
    Stenberg B; With TK
    Acta Derm Venereol Suppl (Stockh); 1982; 100():87-90. PubMed ID: 6962640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.